These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Initial biochemical responses of platelets to stimulation. Mills DC Ciba Found Symp; 1975; 35():153-73. PubMed ID: 179766 [No Abstract] [Full Text] [Related]
4. [Present status and prospects of platelet inhibitors]. Yasunaga K Rinsho Ketsueki; 1976 Jun; 17(6):590-9. PubMed ID: 184313 [No Abstract] [Full Text] [Related]
5. Mode of action of dipyridamole on human platelets. Best LC; McGuire MB; Jones PB; Holland TK; Martin TJ; Preston FE; Segal DS; Russell RG Thromb Res; 1979; 16(3-4):367-79. PubMed ID: 229583 [No Abstract] [Full Text] [Related]
7. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets. Malmsten C; Granström E; Samuelsson B Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797 [No Abstract] [Full Text] [Related]
8. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation. Haslam RJ; Rosson GM Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501 [No Abstract] [Full Text] [Related]
10. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro. Nunn B Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119 [TBL] [Abstract][Full Text] [Related]
11. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation. MacIntyre DE; Handin RI; Rosenberg R; Salzman EW Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842 [No Abstract] [Full Text] [Related]
12. Cyclic nucleotides and aggregation in platelets of spontaneously hypertensive rats. Hamet P; Fraysse J; Franks DJ Circ Res; 1978 Oct; 43(4):583-91. PubMed ID: 210976 [No Abstract] [Full Text] [Related]
13. Studies on the role of cyclic 3',5'-adenosine monophosphate in platelet functions with special reference to aggregation and serotonin release of human blood platelets. Ryo R Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):85-96. PubMed ID: 183445 [No Abstract] [Full Text] [Related]
14. Cadmium-induced platelet hypersensitivity to aggregating agents. Caprino L; Togna G; Togna AR Pharmacol Res Commun; 1979 Oct; 11(9):731-7. PubMed ID: 231263 [No Abstract] [Full Text] [Related]
15. The influence of aspirin and indomethacin on the platelet contractile wave. Gerrard JM; White JG Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974 [TBL] [Abstract][Full Text] [Related]
16. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation. Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet aggregation by papaverine-like drugs: evidence for a novel mechanism of action. Shtacher G; Crowley HJ; Dalton C Biochem Pharmacol; 1976 May; 25(9):1045-50. PubMed ID: 1267850 [No Abstract] [Full Text] [Related]
18. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets. Best LC; Martin TJ; Russell RG; Preston FE Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414 [No Abstract] [Full Text] [Related]
19. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost. Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):839-45. PubMed ID: 7508131 [TBL] [Abstract][Full Text] [Related]
20. Factors affecting platelet cyclic GMP levels during aggregation induced by collagen and by arachidonic acid. Davies T; Davidson MM; McClenaghan MD; Say A; Haslam RJ Thromb Res; 1976 Oct; 9(4):387-405. PubMed ID: 185743 [No Abstract] [Full Text] [Related] [Next] [New Search]